The current standard of staging Hepatitis C patients is through liver biopsies. There are many issues with liver biopsies including accuracy, cost, injury, and how often they can be performed. There is tremendous need for non-invasive methods for staging liver disease and this paper will delve into some of the systems that have already been developed. Many of these new methods are also expensive and contain proprietary algorithms.
This is a formula based on commonly performed blood tests as well as age that gives one number that corresponds to the stage of liver damage developed by Steven Finkbine as part of his doctoral program. The Alchemist Lab Formula, based on inexpensive tests routinely performed, is more accurate than the FibroSure HCV which uses a proprietary algorithm that and a panel of tests which is expensive.